You are viewing the site in preview mode

Skip to main content

Table 2 Pharmacological interventions for which CSRs have reported adverse events in clinical trials; *combinations of a long-acting muscarinic cholinoceptor antagonist with a long-acting β2-adrenoceptor agonist

From: Clinical Study Reports—a systematic review with thematic synthesis: Part 2. Studying benefits, harms, and the benefit to harm balance of pharmacological interventions

Back to article page

Trials

ISSN: 1745-6215